Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 mars 2026 13h42 HE | Source: Faruqi & Faruqi LLP

SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Soleno To Contact Him Directly To Discuss Their Options If you purchased or...
06 mars 2026 17h01 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: uniQure N.V. (QURE) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

uniQure Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or...
06 mars 2026 17h01 HE | Source: Faruqi & Faruqi LLP

NKTR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or...
06 mars 2026 13h11 HE | Source: Faruqi & Faruqi LLP

BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Boston Scientific To Contact Him Directly To Discuss Their Options If you...
04 mars 2026 10h53 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Enphase Energy, Inc. (ENPH) Securities Fraud Class Action – April 20, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

Enphase Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or...
04 mars 2026 10h50 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: BlackRock TCP Capital Corp. (TCPC) Securities Fraud Class Action – April 6, 2026 Lead Plaintiff Deadline - Furuqi & Furuqi LLP

BlackRock Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or...
04 mars 2026 10h49 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Franklin BSP Realty Trust (FBRT) Securities Fraud Class Action – April 27, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

Franklin BSP Realty Trust Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you...
04 mars 2026 10h48 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Inovio Pharmaceuticals (INO) Securities Fraud Class Action – April 7, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

Inovio Pharmaceuticals Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you...
04 mars 2026 10h46 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Kyndryl Holdings, Inc. (KD) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

Kyndryl Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or...
04 mars 2026 10h45 HE | Source: Faruqi & Faruqi LLP

UPCOMING DEADLINE: Mereo BioPharma (MREO) Securities Fraud Class Action – April 6, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP

Mereo BioPharma Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased...

Page suivante